Tagged with “fentanyl”
ArchivesFDA Approves Cancer Breakthrough Pain Drug with Safeguards
The Food and Drug Administration has approved a new opiate drug for severe breakthrough cancer pain. However, Onsolis® will only be available through a restricted distribution program.
As part of an FDA-required Risk Evaluation and Mitigation Strategy, or REMS, only health care providers, pharmacies, and patients registered with the FOCUS program will be able to prescribe, dispense, and use the medicine. Continue reading…
Posted by Kate Murphy on July 16th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: cancer pain, fentanyl, Onsolis
Colorectal Cancer News in Brief: May 15
Despite more resources in large cities, patients were more often diagnosed with cancer at a late stage in cities in Illinois compared to rural areas. Phone calls and personalized diet and exercise plans helped long-term cancer survivors lose weight and gain strength, and scientists have found changes in the blood of family caregivers that promote inflammation and may lead to illness.
In other headlines, both patients and doctors liked virtual, computer videoconferencing visits, and the FDA reports that shortages of fentanyl patches have been resolved. Continue reading…
Posted by Kate Murphy on May 15th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: caregivers, disparities, FDA, fentanyl, survivorship
Follow us on Twitter
Join us on Facebook
Watch us on YouTube
